The present study aims to evaluate the effectiveness of ADHD treatment and the utility of QbCheck in a remote setting, and to test whether improvements in objective ADHD metrics were associated with improvements in patient health and well-being.

ADHD 360 is an innovative, evidence-based digital healthcare service in the UK. Being the largest virtual healthcare service in the United Kingdom, it specializes in the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). ADHD 360 sought to address ongoing challenges in the field related to maintaining accessibility, consistency, and quality of care—areas that are increasingly scrutinized in ADHD service delivery models worldwide.

ADHD 360 incorporated QbCheck, a standardized, objective, and remote ADHD assessment tool, into its clinical workflow. The integration aimed to reduce reliance on subjective symptom reporting, enhance diagnostic accuracy, and optimize clinician time without compromising assessment quality. Given the necessity for robust, efficient, and scalable assessment workflows, QbCheck was utilized to collect objective symptom data remotely, providing clinicians with quantifiable metrics to inform diagnostic interviews and subsequent treatment planning.